- Home
- ASTI vs CERO Comparison
ASTI vs CERO Comparison
Compare ASTI & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- CERO
- Stock Information
- Founded
- ASTI 2005
- CERO 2017
- Country
- ASTI United States
- CERO United States
- Employees
- ASTI N/A
- CERO N/A
- Industry
- ASTI Semiconductors
- CERO
- Sector
- ASTI Technology
- CERO
- Exchange
- ASTI Nasdaq
- CERO Nasdaq
- Market Cap
- ASTI 3.1M
- CERO 3.1M
- IPO Year
- ASTI N/A
- CERO N/A
- Fundamental
- Price
- ASTI $1.68
- CERO $0.89
- Analyst Decision
- ASTI
- CERO Strong Buy
- Analyst Count
- ASTI 0
- CERO 1
- Target Price
- ASTI N/A
- CERO $11.00
- AVG Volume (30 Days)
- ASTI 53.6K
- CERO 4.4M
- Earning Date
- ASTI 05-08-2025
- CERO 04-15-2025
- Dividend Yield
- ASTI N/A
- CERO N/A
- EPS Growth
- ASTI N/A
- CERO N/A
- EPS
- ASTI N/A
- CERO N/A
- Revenue
- ASTI $41,893.00
- CERO N/A
- Revenue This Year
- ASTI N/A
- CERO N/A
- Revenue Next Year
- ASTI N/A
- CERO N/A
- P/E Ratio
- ASTI N/A
- CERO N/A
- Revenue Growth
- ASTI N/A
- CERO N/A
- 52 Week Low
- ASTI $1.17
- CERO $0.53
- 52 Week High
- ASTI $34.00
- CERO $171.00
- Technical
- Relative Strength Index (RSI)
- ASTI 58.20
- CERO 49.91
- Support Level
- ASTI $1.30
- CERO $0.53
- Resistance Level
- ASTI $1.70
- CERO $1.42
- Average True Range (ATR)
- ASTI 0.13
- CERO 0.12
- MACD
- ASTI 0.06
- CERO 0.07
- Stochastic Oscillator
- ASTI 96.23
- CERO 40.19
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.